Evaluation of antineoplastic activity of extracellular asparaginase produced by isolated bacillus circulans

Applied Biochemistry and Biotechnology

Volumn 160, Issue 1, 2010, Pages 72-80

  Prakasham, R S ^a   Hymavathi, M ^a   Subba Rao, Ch ^a   Arepalli, S K ^a   Venkateswara Rao, J ^a   Kennady, P Kavin ^b   Nasaruddin, K ^c   Vijayakumar, J B ^c   Sarma, P N ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^c Bioserve Bio Technologies India Pvt Ltd   (India)

Author keywords

Antineoplastic activity; CCRF CEM cells; Enzyme production; L Asparaginase

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; BACILLUS CIRCULANS; BACTERIAL STRAINS; BIOCHEMICAL CHARACTERIZATION; CANCER CELLS; CELL POPULATIONS; ENZYME PRODUCTION; ERWINIA; EXTRACELLULAR; GLUTAMINASE; L-ASPARAGINASE; MALIGNANT CELLS; PURIFIED ENZYME;

AMINO ACIDS; BACTERIOLOGY; CELL CULTURE; CELL PROLIFERATION; FLOW CYTOMETRY; ORGANIC ACIDS;

ENZYMES;

ASPARAGINASE; GLUTAMINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BACILLUS CIRCULANS; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOCHEMISTRY; CANCER CELL; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; ERWINIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; MOLECULAR WEIGHT;

ANTINEOPLASTIC AGENTS; ASPARAGINASE; BACILLUS; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR SPACE; HUMANS; LEUKEMIA;

BACILLUS CIRCULANS; BACTERIA (MICROORGANISMS); ERWINIA SP.;

EID: 73649121630     PISSN: 02732289     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12010-009-8679-8     Document Type: Article

References (30)

1. T Kristiansen M Einarsson L Sundberg J Porath 1970 FEBS Letters 7 3 294 296 10.1016/0014-5793(70) 80186-7 10.1016/0014-5793(70)80186-7 1:CAS:528:DyaE3cXktlWktbw%3D
2. SM Lee MH Wroble JT Ross 1989 Applied Biochemistry and Biotechnology 22 1 11 10.1007/BF02922693 10.1007/BF02922693 1:CAS:528:DyaL1MXmtFehuro%3D
3. M Duval S Suciu A Ferster X Rialland B Nelken P Lutz, et al. 2002 Blood 99 2734 2739 10.1182/blood.V99.8.2734 10.1182/blood.V99.8.2734 1:CAS:528:DC%2BD38XivVyqurg%3D (Pubitemid 34525359)
4. JD Broome 1961 Nature 191 1114 1115 10.1038/1911114a0 10.1038/1911114a0 1:CAS:528:DyaF38XktFCnsQ%3D%3D
5. TO Yellin JC Wriston 1966 Biochemistry 5 1605 1612 10.1021/bi00869a022 10.1021/bi00869a022 1:CAS:528:DyaF28XhtVKhsLg%3D
6. L Mashburn JC Wriston 1964 Archives of Biochemistry and Biophysics 105 450 452 10.1016/0003-9861(64) 90032-3 10.1016/0003-9861(64)90032-3 1:CAS:528:DyaF2cXkt1Kmurc%3D
7. H Campbell L Mashburn 1969 Biochemistry 9 3768 3775 10.1021/bi00837a042 10.1021/bi00837a042
8. D Ho B Thetford C Carter E Frei 1978 Clinical Pharmacology and Therapeutics 11 408 417
9. MIDM Sarquis EMM Oliveira AS Santos GL da Costa 2004 Mem Inst Oswaldo Cruz, Rio de Janeiro 99 489 492 1:CAS:528:DC%2BD2cXotlyksr0%3D
10. AL Swain M Jaskolski D Housset JK Mohana Rao A Wlodawer 1993 Proc. Natl Acad Sci USA 90 1474 1478 10.1073/pnas.90.4.1474 10.1073/pnas.90.4.1474 1:CAS:528:DyaK3sXitVCrsL4%3D (Pubitemid 23058195)
11. CP Cornea I Lupescu I Vatafu VG Savoiu GH Campeanu 2000 Roum Biotechnology Letters 5 471 478 1:CAS:528:DC%2BD3MXhsFGksLk%3D
12. FS Liu JE Zajic 1973 Applied Microbiology 25 92 96 1:CAS:528: DyaE3sXot12iug%3D%3D
13. S Manna A Sinha R Sadhukhan SL Chakrabarty 1995 Current Microbiology 30 291 298 10.1007/BF00295504 10.1007/BF00295504 1:CAS:528:DyaK2MXkvVKit7w%3D
14. YR Abdel-Fattah ZA Olama 2002 Process Biochem 38 115 122 10.1016/S0032-9592(02) 00067-5 10.1016/S0032-9592(02)00067-5 1:CAS:528:DC%2BD38XktFyntb0%3D
15. CW Radcliffe D Kafkewitz A Abuchowski 1979 Applied and Environmental Microbiology 38 761 762 1:CAS:528:DyaE1MXmtVOitrY%3D
16. RS Prakasham Ch Subba Rao R Sreenivas Rao G Suvarna Lakshmi PN Sarma 2007 J Appl. Microbiol. 102 1382 1391 10.1111/j.1365-2672.2006.03173.x 10.1111/j.1365-2672.2006.03173.x 1:CAS:528:DC%2BD2sXmslKgu7k%3D (Pubitemid 46646628)
17. JC Wriston TO Yellin 1973 Advances in Enzymology 39 185 248 10.1002/9780470122846.ch3 1:CAS:528:DyaE2cXksF2kt74%3D
18. OB Eden MP Shaw JS Lilleyman S Richards 1990 Medical and Pediatric Oncology 18 497 502 10.1002/mpo.2950180612 10.1002/mpo.2950180612 1:STN:280:DyaK3M%2Fkt1Whtg%3D%3D
19. BL Asselin MY Lorenson JC Whitin 1993 Journal of Clinical Oncology 11 1780 1786 1:STN:280:DyaK3szlvF2huw%3D%3D
20. UK Laemmli 1970 Nature 227 680 685 10.1038/227680a0 10.1038/227680a0 1:CAS:528:DC%2BD3MXlsFags7s%3D
21. T Mosmann 1988 Journal of Immunological Methods 65 55 63 10.1016/0022-1759(83) 90303-4 10.1016/0022-1759(83)90303-4
22. RD Jackon RE Handschumacher 1970 Biochemistry 9 3585 3590 10.1021/bi00820a013 10.1021/bi00820a013
23. T Maita G Matsuda 1980 Hoppe-Seyler's Zeitschrift fur Physiologische Chemie 361 105 117 1:CAS:528:DyaL3cXhvFentbg%3D
24. Y Kiriyama M Kubota T Takimoto, et al. 1989 Leukemia 3 294 297 1:STN:280:DyaL1M7otVansA%3D%3D
25. MD Prager N Bachynsky 1968 Biochemical and Biophysical Research Communications 31 43 47 10.1016/0006-291X(68) 90028-4 10.1016/0006-291X(68) 90028-4 1:CAS:528:DyaF1cXhtVehtbY%3D
26. BL Asselin D Ryan CN Frantz 1989 Cancer Research 49 4363 4369 1:CAS:528:DyaL1MXkvV2qt7g%3D
27. T Ueno K Ontawa K Mitusi, et al. 1977 Leukemia 11 1858 1861 10.1038/sj.leu.2400834 10.1038/sj.leu.2400834
28. T Shimizu M Kubota S Adachi 1992 International Journal of Cancer 50 644 648 10.1002/ijc.2910500427 10.1002/ijc.2910500427 1:CAS:528:DyaK38XhvVOlsb0%3D
29. Kurtzberg, J., Yousem, D., & Beauchamp, N. (2003). Cancer Medicine (Vol. IV, pp. 699-705). USA: American Cancer Society. section 13 (Edited by J Holland, E Fries, J Kurtzberg).
30. Chemocare.com. http://www.chemocare.com/bio/erwinia-lasparaginase.asp